<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04228510</url>
  </required_header>
  <id_info>
    <org_study_id>2DSE</org_study_id>
    <nct_id>NCT04228510</nct_id>
  </id_info>
  <brief_title>Two- Dimensional Speckle Tracking Echocardiography After Primary Percutaneous Coronary Intervention</brief_title>
  <official_title>The Role of Two- Dimensional Speckle Tracking Echocardiography in Prediction of Remodeling and Major Adverse Cardiovascular Events in ST Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ST-segment elevation myocardial infarction (STEMI) is a major cause of morbidity and
      mortality worldwide. In spite of decrease in acute and long-term mortality following STEMI in
      parallel with more use of reperfusion therapy, such as primary percutaneous coronary
      intervention (PPCI), modern antithrombotic therapy, and secondary prevention, mortality
      remains considerable. Reduced EF is a well-known predictor of increased short and long term
      major adverse cardiovascular events MACE :( heart failure, stroke and death)
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Incidence of major adverse cardiovascular events</measure>
    <time_frame>1 year</time_frame>
    <description>the rate of Acute coronary syndrome, Heart failure, Stroke and all-cause mortality</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">204</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>ST elevation myocardial infarction (STEMI) patients after primary percutaneous coronary intervention who will be followed up in Assiut University hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>2D speckle tracking echocardiography</intervention_name>
    <description>Global and segmental strain and strain rate in longitudinal and circumferential directions will be detected after PPCI; before discharge. The LV circumferential strains and strain rates will be determined from the short-axis views at the basal, middle, and apical levels, and longitudinal strains and strain rates will be determined from the apical 2-, 3-, and 4-chamber views of the LV.
Segmental longitudinal strains equal to -15% or closer to 0 will be considered abnormal (injured segments). The average segmental longitudinal strain and strain rate of the abnormal segments is defined as the injury longitudinal strain (InjLS) and injury longitudinal systolic strain rate (InjLSRs).</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ST elevation myocardial infarction patients after primary percutaneous coronary
        intervention who will be followed up for a one year in Assiut University hospital.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ST elevation myocardial infarction patients after primary percutaneous coronary
             intervention

        Exclusion Criteria:

          -  Previous myocardial infarction.

          -  Sever or haemodynamically significant (associated with chamber dilation) valvular
             heart diseases.

          -  Previous heart failure.

          -  Previous cerebrovascular strokes.

          -  Atrial fibrillation.

          -  Severe comorbidities as severe renal impairment, hepatic or respiratory failure.

          -  Bad equality views which affects accurate speckle tracking imaging.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hatem Helmy, MD</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aly Tohamy, MD</last_name>
    <phone>01006258877</phone>
    <email>Ali.tohamy@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ayman Khairy, MD</last_name>
    <phone>01094438055</phone>
    <email>Aymankhairy11@gmail.com</email>
  </overall_contact_backup>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 12, 2020</study_first_submitted>
  <study_first_submitted_qc>January 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2020</study_first_posted>
  <last_update_submitted>January 12, 2020</last_update_submitted>
  <last_update_submitted_qc>January 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Waleed Rafat Rasmy</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

